Asthma Therapeutics Market Share

Report ID: GMI8394
   |
Published Date: March 2024
 | 
Report Format: PDF

Download Free PDF

Asthma Therapeutics Market Share

The asthma therapeutics industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness are among a key market strategy for asthma therapeutics product manufacturers. Some of the leading industry players including AstraZeneca, Boehringer Ingelheim GSK plc, and Merck & Co., Inc., among others have a substantial presence in the market.
 

Asthma Therapeutics Market Companies

Some of the eminent market participants operating in the asthma therapeutics industry include:

  • AstraZeneca
  • Boehringer Ingelheim
  • Cipla Ltd.
  • Covis Pharma
  • GSK plc
  • Merck & Co., Inc.
  • Novartis Pharmaceuticals Corporation
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Which companies define the competitive landscape of global asthma therapeutics industry?
AstraZeneca, Boehringer Ingelheim, Cipla Ltd., Covis Pharma, GSK plc, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Teva Pharmaceutical Industries Ltd. are some of the major industry contenders.
How big is the asthma therapeutics market?
Why is the demand for long-term asthma control medications expanding?
What factors are pushing the growth of the North America asthma therapeutics market?
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2023

    Companies covered: 10

    Tables & Figures: 363

    Countries covered: 22

    Pages: 200

    Download Free PDF

    Top